In this review, we explore the molecular underpinnings of SMS and PTLS, focusing on the pathophysiological roles of RAI1, its involvement in critical neuronal pathways, and the emerging landscape of gene- and RNA-based therapies. This evidence concerns the gene RAI1 and Potocki-Lupski syndrome.